University College London

University College London (UCL) is ranked amongst the World’s top universities and is amongst the World’s premier centres for Biomedical research. In the current academic year, ICH has over 500 graduate students of which 178 are research students and 330 pursuing taught courses.

The role  in this project is the development of non-integrating lentiviral vector platform, the development of models of SCID-X1 gene therapy using emerging technologies, mouse models of SCID-X1 for gene targeting and the development of clinical protocols. The keys people are Prof. Adrian Thrasher, the Director of the Centre for Immunodeficiency and the Gene Therapy Programme at ICH and Dr. Fang Zhang, Senior Research Associate and has worked in MIU at ICH since 2003.